Developing new drugs for diseases like Alzheimer’s can be very expensive ... “I think often there’s not a market for repurposed research, because it doesn’t tend to be something that ...
to identify a link between people on the medication and the likelihood of developing vascular dementia. If the results are promising, they hope to move to clinical trials. Dr Susan Kohlhaas, executive ...